Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

Delayed Quote. Delayed  - 04/29 10:00:00 pm
376.71 USD   -3.73%
04/29 REGENERON PHARM : Announces Upcoming 2016 Investor Conference Presen..
04/28DJAmgen Profit Rises 17%, Guidance Raised
04/28DJAmgen Profit Rises 17%, Guidance Raised--Update
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
406.92(c) 406.66(c) 390.28(c) 391.3(c) 376.71(c) Last
376 461 431 013 975 393 924 537 888 901 Volume
+0.63% -0.06% -4.03% +0.26% -3.73% Change
More quotes
Financials ($)
Sales 2016 5 086 M
EBIT 2016 1 825 M
Net income 2016 794 M
Finance 2016 800 M
Yield 2016 -
Sales 2017 5 995 M
EBIT 2017 2 323 M
Net income 2017 1 221 M
Finance 2017 3 780 M
Yield 2017 -
P/E ratio 2016 61,34
P/E ratio 2017 37,65
EV / Sales 2016 7,63x
EV / Sales 2017 5,97x
Capitalization 39 584 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.The company involves in marketing medicines for eye diseases, colorectal cancer and a rare inflammatory... 
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
04/29 REGENERON PHARMACEUTICALS : Announces Upcoming 2016 Investor Conference Presenta..
04/28DJAmgen Profit Rises 17%, Guidance Raised
04/28 REGENERON PHARMACEUTICALS : Patent Issued for System and Methods for Use in Disp..
04/28DJAmgen Profit Rises 17%, Guidance Raised--Update
04/28 REGENERON PHARMACEUTICALS : Researchers Submit Patent Application, "Use of a Veg..
04/28 REGENERON PHARMACEUTICALS : New Immunoglobulins Findings from Regeneron Pharmace..
04/28 REGENERON PHARMACEUTICALS : Reports Outline Solid Cancer Findings from Regeneron..
04/28DJAmgen Profit Rises 17%, Guidance Raised
More news
Sector news : Bio Therapeutic Drugs
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
04/29DJSanofi Seeks Talks With Medivation Over $9.3 Billion Offer -- 2nd Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/22 Transports, Biotechs, And Small-Caps Spring Back To Life
04/21 An Outlook On Regeneron Pharmaceuticals
04/21 Rotating Into Health Care
04/16 Avoid J.C. Penney - Cramer's Lightning Round (4/15/16)
04/13 BIOTECH FORUM DAILY DIGEST : Medivation Buyout In The Works? Regeneron Moves Int..


Comments 
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends REGENERON PHARMAC...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions